Philip H Sanford Net Worth

What's Philip Sanford's mailing address?

Philip's mailing address filed with the SEC is C/O NEPTUNE WELLNESS SOLUTIONS INC., 100-545 PROMENADE DU CENTROPOLIS, LAVAL, A8, H7T 0A3.

Insiders trading at Neptune Wellness Solutions Inc

Over the last 3 years, insiders at Neptune Wellness Solutions Inc have traded over $648,862 worth of Neptune Wellness Solutions Inc stock. The most active insiders traders include Michael Cammarata, Securities Settlement Fund ... y Raymond Silcock. On average, Neptune Wellness Solutions Inc executives and independent directors trade stock every 58 days with the average trade being worth of $121,241. The most recent stock trade was executed by Securities Settlement Fund ... on 1 March 2024, trading 81,814 units of NEPT stock currently worth $35,180.

What does Neptune Wellness Solutions Inc do?

vision: provide great products and solutions that deliver optimal health and wellness. mission: leverage our scientific and innovative expertise to create and provide our customers globally with the best nutritional products and wellness solutions. neptune is active in five main areas: cannabis business: neptune is working to develop unique extracts and formulations in the legal cannabis wellness field. ingredients: leveraging our global network of suppliers, we source a variety of marine oils, seed oils and specialty ingredients. turnkey solutions: we develop product concepts in collaboration with our customers (branded marketers) as turnkey finished supplements that are ready for sale under their brand, primarily as softgels, capsules, liquids and powders. through our global network of suppliers, we source ingredients and formulate the ideal product. the ingredients are sent to third-party manufacturers, where the formula is developed in a liquid, powder or capsule form and then pack

Neptune Wellness Solutions Inc executives and stock owners

Neptune Wellness Solutions Inc executives and other stock owners filed with the SEC include:

• Michael Cammarata,
  President, Chief Executive Officer, Director
• Graham Wood,
  Chief Scientific Officer
• Jacqueline Khayat,
  Vice President, Business Development – Cannabis Business
• Dr. Toni Rinow MBA., Ph.D.,
  Chief Operating Officer
• Michel Timperio,
  President - Cannabis Business
• Jean-Daniel Belanger,
  Vice President, Legal Affairs & Corporate Secretary
• Russel Jay,
  VP of Sales in USA
• Toni Rinow,
  Chief Financial Officer, Vice President
• Christopher Piazza,
  Sr. Legal Counsel & Assistant Corp. Sec.
• John Moretz,
  Independent Chairman of the Board
• Scott Winkle,
  Investor Relations
• Richard Schottenfeld,
  Independent Director
• Ronald Denis,
  Independent Director
• Michael De Geus,
  Independent Director
• Joseph Buaron,
  Independent Director
• Russell Jay,
  Vice President of U.S. Sales
• Robert Dipede,
  Senior Vice President of Biodroga and Health & Wellness Innovation
• David Mayers,
  Chief Operating Officer
• Marc Vaugeois,
  VP of Sales
• Morry Brown,
  VP of Investor Relations
• Jessica Adkins,
  Sr. VP of Corp. Communications
• Gary S. Kaminsky,
  Sr. VP of Compliance & Legal Affairs
• John Wirt,
  Gen. Counsel
• Steve Wayne West,
  VP of Investor Relations
• Randy Weaver,
  Interim Chief Financial Officer
• Roger Corriveau,
  Vice-Pres of Bus. Devel.
• Sabrina Di Blasio,
  Director of Marketing & Communications
• Jean-Daniel Bélanger,
  VP of Legal Affairs & Corp. Sec.
• John Ripplinger,
  Director of Investor Relations
• Stephen Lijoi,
  VP Operations
• James S. Hamilton,
  Advisor
• Securities Settlement Fund ...,
  10% owner
• Philip H Sanford,
  Director
• Raymond Silcock,
  Chief Financial Officer